Faricimab 21mg/0.175ml solution for injection pre-filled syringes
NHS hospitals in England used £364,079,312 of indicative cost of Faricimab 21mg/0.175ml solution for injection pre-filled syringes in the 12 months to July 2026, about 1.4% of all hospital medicines spend. That is up 25.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Faricimab 21mg/0.175ml solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Faricimab 21mg/0.175ml solution for injection pre-filled syringes most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Moorfields Eye Hospital Nhs Ft | £10,657,750 |
| Aintree University Hospital Nhs Ft | £10,472,687 |
| Colchester Hospital University Nhs Ft | £10,354,421 |
| South Tees Hosp Nhs Foundation Trust | £10,087,820 |
| Hull And East Yorkshire Hpls Nhs Trust | £9,792,180 |
| Gloucestershire Hpls Nhs Foundation Trst | £8,943,848 |
| Univ Hpls Bristol Nhs Foundation Trust | £8,507,610 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £8,489,589 |
| University Hospital Southampton Nhs Ft | £8,245,221 |
| Manchester University Nhs Ft | £8,101,294 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.